NEW YORK (GenomeWeb News) – Two more Japanese companies have licensed Oxford Gene Technology’s oligonucleotide microarray patents to sell arrays, OGT said today.
 
Bio Matrix Research, a bio venture company launched by Tokyo University of Science, will develop and commercialize products and microarrays to be marketed in Japan, the company said.
 
Filgen will conduct a microarray service in Japan using licensed microarrays.
 
The licenses will remain valid for the patents’ lifetime.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.